286 related articles for article (PubMed ID: 28133796)
21. HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo Activation.
Dai K; Khan SN; Wang Y; He L; Guenaga J; Ingale J; Sundling C; O'Dell S; McKee K; Phad G; Corcoran M; Wilson R; Mascola JR; Zhu J; Li Y; Karlsson Hedestam GB; Wyatt RT
Sci Rep; 2016 Feb; 6():20987. PubMed ID: 26879974
[TBL] [Abstract][Full Text] [Related]
22. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.
Hulot SL; Korber B; Giorgi EE; Vandergrift N; Saunders KO; Balachandran H; Mach LV; Lifton MA; Pantaleo G; Tartaglia J; Phogat S; Jacobs B; Kibler K; Perdiguero B; Gomez CE; Esteban M; Rosati M; Felber BK; Pavlakis GN; Parks R; Lloyd K; Sutherland L; Scearce R; Letvin NL; Seaman MS; Alam SM; Montefiori D; Liao HX; Haynes BF; Santra S
J Virol; 2015 Jun; 89(12):6462-80. PubMed ID: 25855741
[TBL] [Abstract][Full Text] [Related]
25. Characterization of human IgG repertoires in an acute HIV-1 infection.
Chen W; Prabakaran P; Zhu Z; Feng Y; Streaker ED; Dimitrov DS
Exp Mol Pathol; 2012 Dec; 93(3):399-407. PubMed ID: 23036472
[TBL] [Abstract][Full Text] [Related]
26. Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopes.
Das S; Boliar S; Mitra N; Samal S; Bansal M; Koff WC; Chakrabarti BK
Retrovirology; 2016 Nov; 13(1):81. PubMed ID: 27871328
[TBL] [Abstract][Full Text] [Related]
27. Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design.
Sadanand S; Suscovich TJ; Alter G
Annu Rev Med; 2016; 67():185-200. PubMed ID: 26565674
[TBL] [Abstract][Full Text] [Related]
28. Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.
Derby NR; Kraft Z; Kan E; Crooks ET; Barnett SW; Srivastava IK; Binley JM; Stamatatos L
J Virol; 2006 Sep; 80(17):8745-62. PubMed ID: 16912322
[TBL] [Abstract][Full Text] [Related]
29. What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?
Alexander MR; Ringe R; Sanders RW; Voss JE; Moore JP; Klasse PJ
J Virol; 2015 Jun; 89(11):5981-95. PubMed ID: 25810537
[TBL] [Abstract][Full Text] [Related]
30. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
Sun Z; Li J; Hu X; Shao Y; Zhang MY
Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
[TBL] [Abstract][Full Text] [Related]
31. Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention.
Brady JM; Baltimore D; Balazs AB
Immunol Rev; 2017 Jan; 275(1):324-333. PubMed ID: 28133808
[TBL] [Abstract][Full Text] [Related]
32. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
[TBL] [Abstract][Full Text] [Related]
33. Differences in Allelic Frequency and CDRH3 Region Limit the Engagement of HIV Env Immunogens by Putative VRC01 Neutralizing Antibody Precursors.
Yacoob C; Pancera M; Vigdorovich V; Oliver BG; Glenn JA; Feng J; Sather DN; McGuire AT; Stamatatos L
Cell Rep; 2016 Nov; 17(6):1560-1570. PubMed ID: 27806295
[TBL] [Abstract][Full Text] [Related]
34. Genetic and structural analyses of affinity maturation in the humoral response to HIV-1.
Kepler TB; Wiehe K
Immunol Rev; 2017 Jan; 275(1):129-144. PubMed ID: 28133793
[TBL] [Abstract][Full Text] [Related]
35. Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women.
Mkhize NN; Durgiah R; Ashley V; Archary D; Garrett NJ; Karim QA; Karim SS; Moore PL; Yates N; Passmore JA; Tomaras GD; Morris L
AIDS; 2016 Apr; 30(7):1005-14. PubMed ID: 26836790
[TBL] [Abstract][Full Text] [Related]
36. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
McBurney SP; Young KR; Ross TM
Virology; 2007 Feb; 358(2):334-46. PubMed ID: 17011011
[TBL] [Abstract][Full Text] [Related]
37. Rational antibody-based HIV-1 vaccine design: current approaches and future directions.
Walker LM; Burton DR
Curr Opin Immunol; 2010 Jun; 22(3):358-66. PubMed ID: 20299194
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of an HIV-1 envelope glycoprotein-specific B-cell from an immortalized human naïve B-cell library.
Sun Z; Lu S; Yang Z; Li J; Zhang M
J Gen Virol; 2017 Apr; 98(4):791-798. PubMed ID: 28073404
[TBL] [Abstract][Full Text] [Related]
39. The Antibody Germline/Maturation Hypothesis, Elicitation of Broadly Neutralizing Antibodies Against HIV-1 and Cord Blood IgM Repertoires.
Prabakaran P; Chen W; Dimitrov DS
Front Immunol; 2014; 5():398. PubMed ID: 25221552
[TBL] [Abstract][Full Text] [Related]
40. A method for identification of HIV gp140 binding memory B cells in human blood.
Scheid JF; Mouquet H; Feldhahn N; Walker BD; Pereyra F; Cutrell E; Seaman MS; Mascola JR; Wyatt RT; Wardemann H; Nussenzweig MC
J Immunol Methods; 2009 Apr; 343(2):65-7. PubMed ID: 19100741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
